Article

Disease progression and survival with human immunodeficiency virus type 1 subtype E infection among female sex workers in Thailand

Mahidol University, Krung Thep, Bangkok, Thailand
The Journal of Infectious Diseases (Impact Factor: 5.78). 05/2000; 181(5):1598-606. DOI: 10.1086/315469
Source: PubMed

ABSTRACT This study describes rates and correlates of disease progression and survival among 194 female sex workers in northern Thailand who were infected with human immunodeficiency virus type 1 (HIV-1; 96% with subtype E). The median rate of CD4 T lymphocyte decline (3.9 cells/microL/month), median time from infection to <200 CD4 T lymphocytes/microL (6.9 years), and time to 25% mortality (6.0 years) were similar to those found in studies performed in Western countries before highly active antiretroviral therapy was available to populations infected with HIV-1 subtype B. Mortality rates among women with >100,000 HIV-1 RNA copies/mL were 15.4 times higher (95% confidence interval, 5.2-45.2) than among women with <10,000 copies. Initial CD4 T lymphocyte counts and serum virus load were independently strong predictors of survival. These results can help in assessing the effects of the epidemic in Thailand and in determining the prognoses for individual patients.

0 Followers
 · 
51 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Purpose We aimed to characterize the antiretroviral therapy (ART) cascade among female sex workers (FSWs) globally. Methods We systematically searched PubMed, Embase and MEDLINE in March 2014 to identify studies reporting on ART uptake, attrition, adherence, and outcomes (viral suppression or CD4 count improvements) among HIV-infected FSWs globally. When possible, available estimates were pooled using random effects meta-analyses (with heterogeneity assessed using Cochran's Q test and I2 statistic). Results 39 studies, reporting on 21 different FSW study populations in Asia, Africa, North America, South America, and Central America and the Caribbean, were included. Current ART use among HIV-infected FSWs was 38% (95% CI: 29%–48%, I2 = 96%, 15 studies), and estimates were similar between high-, and low- and middle-income countries. Ever ART use among HIV-infected FSWs was greater in high-income countries (80%; 95% CI: 48%–94%, I2 = 70%, 2 studies) compared to low- and middle-income countries (36%; 95% CI: 7%–81%, I2 = 99%, 3 studies). Loss to follow-up after ART initiation was 6% (95% CI: 3%–11%, I2 = 0%, 3 studies) and death after ART initiation was 6% (95% CI: 3%–11%, I2 = 0%, 3 studies). The fraction adherent to ≥95% of prescribed pills was 76% (95% CI: 68%–83%, I2 = 36%, 4 studies), and 57% (95% CI: 46%–68%, I2 = 82%, 4 studies) of FSWs on ART were virally suppressed. Median gains in CD4 count after 6 to 36 months on ART, ranged between 103 and 241 cells/mm3 (4 studies). Conclusions Despite global increases in ART coverage, there is a concerning lack of published data on HIV treatment for FSWs. Available data suggest that FSWs can achieve levels of ART uptake, retention, adherence, and treatment response comparable to that seen among women in the general population, but these data are from only a few research settings. More routine programme data on HIV treatment among FSWs across settings should be collected and disseminated.
    PLoS ONE 09/2014; 9(9). DOI:10.1371/journal.pone.0105645 · 3.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Concern about a possible association of hormonal contraception with HIV acquisition has been raised by three types of evidence. Firstly, high-dose progestogen treatment greatly increases HIV acquisition in female non-human primates. Secondly, biological plausibility for a link between hormonal contraception anf HIV acquisition is provided by evidence of a hypo-oestrogenic state induced by progestogen contraception with vaginal mucosal thinning, and evidence of effects on the humoral and cellular immune systems. Thirdly, some but not other large observational studies have found an increase in HIV acquisition among women using hormonal contraception.
    Cochrane database of systematic reviews (Online) 05/2014; 5(5):CD009741. DOI:10.1002/14651858.CD009741.pub2 · 5.70 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In the natural history of Human Immunodeficiency Virus Type-1 (HIV-1) infection, many studies included the participants who were seropos-itive at time of enrollment. Estimation of the unknown times since exposure to HIV-1 in the prevalent cohorts is of primary importance for estimation of the incubation period of Acquired Immunodeficiency Syndrome (AIDS). To estimate incubation period of AIDS we used prior distribution of incubation times, based on a external data as suggested by Bacchetti and Jewell (1991, Biometrics, 47,947-960). In the present study, our estimate was nonpara-metric based on a method proposed by Wang, Jewell and Tsai (1986, Annals of Statistics, 14, 1597-1605).
    Journal of data science: JDS 04/2007; 5:289-296.